An update on inflammatory breast cancer

Oncology Reviews

Volumn 3, Issue 2, 2009, Pages 73-78

  Thapaliya, P ^a   Karlin, N J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Breast cancer; Inflammatory; Lymphovascular invasion; Metastasis

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BEVACIZUMAB; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FLUOROURACIL; GUANOSINE TRIPHOSPHATASE; KI 67 ANTIGEN; LAPATINIB; MUCIN 1; PACLITAXEL; PROGESTERONE RECEPTOR; PROTEIN P53; TAXANE DERIVATIVE; TRASTUZUMAB; UVOMORULIN;

ADJUVANT THERAPY; AUTOLOGOUS STEM CELL TRANSPLANTATION; BREAST CANCER; BREAST CONSERVING SURGERY; BREAST RECONSTRUCTION; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE FREE SURVIVAL; HUMAN; INFLAMMATORY BREAST CANCER; INFLAMMATORY DISEASE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

EID: 67650649965     PISSN: 19705557     EISSN: 19705565     Source Type: Journal    
DOI: 10.1007/s12156-009-0010-y     Document Type: Review

References (48)

1. Y Gong 2008 Pathologic aspects of inflammatory breast cancer (part 2): biologic insights into its aggressive phenotype Semin Oncol 35 1 33 40 (Pubitemid 351282394)
2. AK Kidwell 2007 Inflammatory breast cancer: a race against time JAAPA 20 9 40 44
3. E Resetkova 2008 Pathologic aspects of inflammatory breast carcinoma: part 1: histomorphology and differential diagnosis Semin Oncol 35 1 25 32 (Pubitemid 351282393)
4. SE Singletary M Cristofanilli 2008 Defining the clinical diagnosis of inflammatory breast cancer Semin Oncol 35 1 7 10 (Pubitemid 351282390)
5. C Blum M Baker 2008 Venous congestion of the breast mimicking inflammatory breast cancer: case report and review of literature Breast J 14 1 97 101
6. U Güth E Wight G Singer 2006 Breast cancer with noninflammatory skin involvement: new data revise the traditional image of a "classical" clinicopathologic entity Praxis 95 47 1829 1835 (Pubitemid 44862140)
7. U Güth G Singer A Schötzau I Langer 2005 Scope and significance of non-uniform classification practices in breast cancer with non-inflammatory skin involvement: a clinicopathologic study and an international survey Ann Oncol 16 10 1618 1623 (Pubitemid 41510135)
8. PH Levine C Veneroso 2008 The epidemiology of inflammatory breast cancer Semin Oncol 35 1 11 16 (Pubitemid 351282398)
9. WF Anderson C Schairer BE Chen 2006 Epidemiology of inflammatory breast cancer (IBC) Breast Dis 22 9 23
10. M Espié JM Extra A de Roquancourt 1995 Inflammatory cancer of the breast: review and experience at Saint-Louis Hospital Arch Anat Cytol Pathol 43 1-2 36 43
11. SH Giordano GN Hortobagyi 2003 Inflammatory breast cancer: clinical progress and the main problems that must be addressed Breast Cancer Res 5 6 284 288
12. E Khanafshar J Phillipson DP Schammel 2005 Inflammatory myofibroblastic tumor of the breast Ann Diagn Pathol 9 3 123 129 (Pubitemid 40797924)
13. S Chia SM Swain DR Byrd 2008 Locally advanced and inflammatory breast cancer J Clin Oncol 10 26 5 786 790 (Pubitemid 351264392)
14. LY Dirix P Van Dam A Prové 2006 Inflammatory breast cancer: current understanding Curr Opin Oncol 18 6 563 571 (Pubitemid 44427629)
15. CN Coleman PE Wallner JS Abrams 2003 Inflammatory breast issue J Natl Cancer Inst 20 95 16 1182 1183
16. M Wu SD Merajver 2005 Molecular biology of inflammatory breast cancer: applications to diagnosis, prognosis, and therapy Breast Dis 22 25 34 (Pubitemid 44308939)
17. JS Tomlinson ML Alpaugh SH Barsky 2001 An intact, overexpressed E-cadherin/alpha, beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast cancer Cancer Res 61 13 5231 5241 (Pubitemid 32681558)
18. K van Golen 2003 Inflammatory breast cancer: relationship between growth factor signaling and motility in aggressive cancers Breast Cancer Res 5 3 174 179
19. CV Hojilla GA Wood R Khokha 2008 Inflammation and breast cancer: metalloproteinases as common effectors of inflammation and extracellular matrix breakdown in breast cancer Breast Cancer Res 10 2 205
20. CL Wiseman 1995 Inflammatory breast cancer: 10-year follow-up of a trial of surgery, chemotherapy, and allogeneic tumor cell/BCG immunotherapy Cancer Invest 13 3 267 271
21. R Sacco A Carpino S Bolognini 1994 Inflammatory carcinoma of the breast: the immunological findings Minerva Chir 49 12 1351 1356
22. E Charafe-Jauffret C Tarpin P Viens 2008 Defining the molecular biology of inflammatory breast cancer Semin Oncol 35 1 41 50 (Pubitemid 351282395)
23. CM Perou T Sorlie MB Eisen 2000 Molecular portraits of human breast tumors Nature 406 6797 747 752 (Pubitemid 30671230)
24. F Bertucci P Finetti J Rougemont 2005 Gene expression profiling identifies molecular subtypes of inflammatory breast cancer Cancer Res 65 2170 2178 (Pubitemid 40490124)
25. R Rouzier CM Perou WF Symmans 2005 Breast cancer molecular subtypes respond differently to preoperative chemotherapy Clin Cancer Res 11 16 5678 5685 (Pubitemid 41170290)
26. M Ayers WF Symmans J Stec 2004 Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel, and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer J Clin Oncol 22 12 2284 2293 (Pubitemid 41115384)
27. WT Yang HT Le-Petross H Macapinlac 2008 Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings Breast Cancer Res Treat 109 3 417 426 (Pubitemid 351692058)
28. JM Sabaté M Clotet A Gómez 2005 Radiologic evaluation of uncommon inflammatory and reactive breast disorders Radiographics 25 2 411 424 (Pubitemid 40547057)
29. CH Le-Petross L Bidaut WT Yang 2008 Evolving role of imaging modalities in inflammatory breast cancer Semin Oncol 35 1 51 63 (Pubitemid 351282396)
30. GT Mogavero EK Fishman JE Kuhlman 1992 Inflammatory breast cancer: CT evaluation Clin Imaging 16 3 183 186
31. D Fuster J Duch P Paredes 2008 Preoperative staging of large primary breast cancer with [18]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures J Clin Oncol 26 29 4746 4751
32. S Dawood NT Ueno M Cristofanilli 2008 The medical treatment of inflammatory breast cancer Semin Oncol 35 1 64 71 (Pubitemid 351282392)
33. SE Singletary 2008 Surgical management of inflammatory breast cancer Semin Oncol 35 1 72 77 (Pubitemid 351282388)
34. G Franceschini D Terribile C Fabbri 2007 Management of locally advanced breast cancer Minerva Chir 62 4 249 255
35. L Mauriac G MacGrogan A Avril 1999 Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS) Ann Oncol 10 1 47 52
36. P Broet SM Scholl A de la Rochefordiere 1999 Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial Breast Cancer Res Treat 58 2 151 156 (Pubitemid 30032487)
37. VF Semiglazov EE Topuzov JL Bavli 1994 Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiation alone in stage IIB-IIIa breast cancer Ann Oncol 5 7 591 595 (Pubitemid 24283094)
38. A Makris TJ Powles SE Ashley 1998 A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer Ann Oncol 9 11 1179 1184 (Pubitemid 28552806)
39. B Fisher J Bryant N Wolmark 1998 Effects of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol 16 8 2672 2685 (Pubitemid 28363030)
40. JA van der Hage CJ van de Veide JP Julien 2001 Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902 J Clin Oncol 19 22 4224 4237 (Pubitemid 33081640)
41. JC Gazet HT Ford R Gray 2001 Estrogen-receptor-directed neoadjuvant therapy for breast cancer: results of a randomized trial using formestane and methotrexate, mitoxantrone and mitomycin C (MMM) chemotherapy Ann Oncol 12 5 685 691 (Pubitemid 32519923)
42. SM Scholl B Asselain T Palangie 1991 Neoadjuvant chemotherapy in operable breast cancer Eur J Cancer 27 12 1668 1671
43. MJ Lopez KA Porter 1996 Inflammatory breast cancer Surg Clin North Am 76 2 411 429 (Pubitemid 26119157)
44. WA Woodward TA Buchholz 2008 The role of locoregional therapy in inflammatory breast cancer Semin Oncol 35 1 78 86 (Pubitemid 351282389)
45. WJ Gradishar 1996 Inflammatory breast cancer: the evolution of multimodality treatment strategies Semin Surg Oncol 12 5 352 363 (Pubitemid 26300015)
46. SE Singletary FC Ames AU Buzdar 1994 Management of inflammatory breast cancer World J Surg 18 1 87 92 (Pubitemid 24100698)
47. IA Jaiyesimi AU Buzdar G Hortobagyi 1992 Inflammatory breast cancer: a review J Clin Oncol 10 6 1014 1018
48. MR Kell M Morrow 2005 Surgical aspects of inflammatory breast cancer Breast Dis 22 67 73 (Pubitemid 44308943)